Skip to main content

Advertisement

Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Article metrics

Unfortunately, the original version of this article [1] contained an error. The original article was published containing two incorrect sentences.

This sentence appeared in the abstract as follows “A significant difference was observed between patients who had taken PPI and who not with ORR (46.9 vs. 67.7 %, p = 0.049) and median TTP (9.7 months vs. 8.7 months, p = 0.045).” This should have read as “A significant difference was observed between patients who had taken PPI and who not with ORR (67.7 vs. 46.9 %, p = 0.049) and median TTP (9.7 months vs. 8.7 months, p = 0.045).”

The following sentence which appeared in the main text was also incorrect. In the original article it read as “As planned, we compared the pool of patients receiving PPI to those treated exclusively with chemotherapy and the statistical analysis showed a significant difference in term of ORR between patients who received PPI, as compared to those treated with chemotherapy alone (46.9 vs. 67.7 %, p = 0.049).” However this should have read as “As planned, we compared the pool of patients receiving PPI to those treated exclusively with chemotherapy and the statistical analysis showed a significant difference in term of ORR between patients who received PPI, as compared to those treated with chemotherapy alone (67.7 vs. 46.9 %, p = 0.049).”

Both sentences have now been corrected in the original article. The author apologizes for any inconvenience caused.

Reference

  1. 1.

    J Exp Clin Cancer Res. 2015; 34:85. doi:10.1186/s13046-015-0194-x.

Download references

Author information

Correspondence to Stefano Fais or Xi-Chun Hu.

Additional information

Bi-Yun Wang and Jian Zhang contributed equally to this work.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, B., Zhang, J., Wang, J. et al. Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. J Exp Clin Cancer Res 34, 109 (2015) doi:10.1186/s13046-015-0220-z

Download citation

Keywords

  • Public Health
  • Breast Cancer
  • Cancer Research
  • Metastatic Breast Cancer
  • Metastatic Breast